Publication | Open Access
Site specificity of the inhibitory effects of oligo(nucleoside methylphosphonate)s complementary to the acceptor splice junction of herpes simplex virus type 1 immediate early mRNA 4.
137
Citations
31
References
1989
Year
Viral ReplicationImmunologyMolecular BiologyAntiviral DrugVirus StructureSpecific InhibitionAntiviral Drug DevelopmentSplice JunctionSite SpecificityVirus GeneViral GeneticsNucleoside MethylphosphonateVirologyGene ExpressionCell BiologyMolecular VirologyVirus GrowthNatural SciencesPathogenesisHerpesvirusesMedicineAcceptor Splice Junction
Oligo(nucleoside methylphosphonate)s complementary to the splice junction of herpes simplex virus type 1 immediate early pre-mRNAs 4 and 5 caused specific inhibition of herpes simplex virus type 1 growth. The dodecamer d(TpTCCTCCTGCGG) (deoxynucleoside methylphosphonate residues in italic) caused 50% and 98% decreases in herpes simplex virus type 1 titers at concentrations of 15 microM and 100 microM, respectively. d(TpTCCTCCTGCGG) inhibited viral but not cellular protein synthesis and decreased splicing of immediate early pre-mRNAs 4 and 5. Inhibition was highly sequence specific. A psoralen derivative of d(TpTCCTCCTGCGG) that can covalently bind to complementary sequences after exposure to 365-nm irradiation caused 90-98% inhibition of virus growth in cells treated with oligomer (5 microM) and irradiated at 1-3 hr postinfection. The data suggest that oligo(nucleoside methylphosphonate)s of appropriate sequence and derivatization may be effective as antiviral agents.
| Year | Citations | |
|---|---|---|
Page 1
Page 1